|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||81.12 / 121.75|
In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Edwards Lifesciences Corp has taken over the #82 spot from Western Digital Corp , according to ETF Channel. Below is a chart of Edwards Lifesciences Corp versus Western Digital Corp plotting their respective rank within the S&P 500 over time (EW plotted in blue; WDC plotted in green): In forming the rank, the analyst opinions from the major brokerage houses were tallied, and averaged; then, the underlying components were ranked according to those averages.
Now accepting grant proposals to help address the global burden of heart valve disease
Concert must submit toxicology data to the FDA before proceeding with Phase 2 trials.
Canaccord is bullish on Edwards Lifescience stock.
Here are Thursday's top research calls, including downgrades for CVS, Edwards Lifesciences and Qorvo, and an upgrade for Tesoro.
However, more consolidation may be needed before the uptrend resumes.
The small business survey signals more building, more hiring, and more buying, Jim Cramer says.
Still, volume and positive money flow will need to improve to sustain a breakout move in the name.
The health care sector has been a miserable performer lately -- but these five health trades are bucking the trend.
As the dominant player in the transcatheter aortic valve replacement market, Edwards doesn't 'need' large deals.
Insiders at these companies have been scooping up shares of their own stock lately.
Cramer says he likes Twilio for the long term and is taking Nvidia over Himax.
When it comes to growth, what's good for the American people may also now be good for stocks, Cramer says.
These stocks are down some 20% over the last 30 months and look ripe for a rise.